Armistice Capital Master Fund Ltd., 10% Owner at AMAG PHARMACEUTICALS, INC. (AMAG), bought 37,398 shares at $12.43 ($462K) on 2020-01-09, disclosed to the SEC on 2020-01-13.
Open-market purchase of $462k AMAG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.33 | 12,466 | $154K | 33.2% |
| 2 | $12.33 | 12,466 | $154K | 33.2% |
| 3 | $12.43 | 12,466 | $155K | 33.5% |
| Total | $12.36 avg | 37,398 | $462K | 100% |
| Filing → |
| AVTX | BUY | 2022-01-11 | $1.1M | — | Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |